ATE502046T1 - T-zellen-epitope des cyn-d-1-allergens aus bermudagraspollen - Google Patents

T-zellen-epitope des cyn-d-1-allergens aus bermudagraspollen

Info

Publication number
ATE502046T1
ATE502046T1 AT02766955T AT02766955T ATE502046T1 AT E502046 T1 ATE502046 T1 AT E502046T1 AT 02766955 T AT02766955 T AT 02766955T AT 02766955 T AT02766955 T AT 02766955T AT E502046 T1 ATE502046 T1 AT E502046T1
Authority
AT
Austria
Prior art keywords
bermuda grass
grass pollen
molecules
cyn
allergen
Prior art date
Application number
AT02766955T
Other languages
English (en)
Inventor
Robyn O'hehir
Jennifer Rolland
Original Assignee
Circassia Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Circassia Ltd filed Critical Circassia Ltd
Application granted granted Critical
Publication of ATE502046T1 publication Critical patent/ATE502046T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • A61K39/36—Allergens from pollen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/16—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from plants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Public Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Polyamides (AREA)
AT02766955T 2001-09-18 2002-09-18 T-zellen-epitope des cyn-d-1-allergens aus bermudagraspollen ATE502046T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPR7754A AUPR775401A0 (en) 2001-09-18 2001-09-18 Novel Epitopes and Uses Thereof
PCT/AU2002/001283 WO2003024998A1 (en) 2001-09-18 2002-09-18 T cell epitopes of the cyn d 1 allergen from bermuda grass pollen

Publications (1)

Publication Number Publication Date
ATE502046T1 true ATE502046T1 (de) 2011-04-15

Family

ID=3831594

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02766955T ATE502046T1 (de) 2001-09-18 2002-09-18 T-zellen-epitope des cyn-d-1-allergens aus bermudagraspollen

Country Status (8)

Country Link
US (2) US20050075481A1 (de)
EP (1) EP1436320B1 (de)
AT (1) ATE502046T1 (de)
AU (1) AUPR775401A0 (de)
DE (1) DE60239477D1 (de)
DK (1) DK1436320T3 (de)
ES (1) ES2362040T3 (de)
WO (1) WO2003024998A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007030748A2 (en) * 2005-09-09 2007-03-15 The University Of Chicago Methods and compositions for diagnosis and immunotherapy of pollen allergy
BRPI0815395A2 (pt) * 2007-08-15 2015-02-10 Circassia Ltd Composição, vetor, produto, formulação farmacêutica, me´todo in vitro para determinar se as células t reconhecem um polipeptídeo, e, método in vitro para determinar se um indivíduo se encontra ou está em risco de uma condição.
US20110014238A1 (en) * 2007-10-22 2011-01-20 Cooperative Research Centre For Asthma Immunogenic protein pas n 1 from bahia grass pollen
AU2013202362B2 (en) * 2009-02-05 2015-09-17 Circassia Limited Grass Peptides for Vaccine
SI2393830T1 (sl) * 2009-02-05 2015-04-30 Circassia Limited Travni peptidi za cepivo
BR112014019504A2 (pt) * 2012-02-07 2017-06-27 La Jolla Inst Allergy & Immunology alérgenos da erva-dos-prados e métodos e usos para modulação de resposta imune
WO2017004561A1 (en) 2015-07-01 2017-01-05 Alk-Abelló A/S Peptide combinations and uses thereof for treating grass allergy
EP3672600A4 (de) 2017-08-21 2021-05-19 Glycom A/S Synthetische zusammensetzung zur verminderung von allergiesymptomen

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1340729C (en) 1988-03-23 1999-09-07 Mohan Bir Singh Ryegrass pollen allergen
WO1992016554A1 (en) 1991-03-14 1992-10-01 The University Of Melbourne Protein allergens of the species cynodon dactylon
EP0668915A1 (de) * 1991-11-15 1995-08-30 The University Of Melbourne Protein allergene von spezius cynodon dactylon
US6214358B1 (en) * 1992-10-30 2001-04-10 Immulogic Pharamaceutical Corp. Protein allergens of the species Cynodon dactylon
US5480972A (en) * 1992-10-30 1996-01-02 The University Of Melbourne Allergenic proteins from Johnson grass pollen

Also Published As

Publication number Publication date
DE60239477D1 (de) 2011-04-28
US20050075481A1 (en) 2005-04-07
WO2003024998A1 (en) 2003-03-27
US20110217325A1 (en) 2011-09-08
EP1436320B1 (de) 2011-03-16
US9120865B2 (en) 2015-09-01
AUPR775401A0 (en) 2001-10-11
DK1436320T3 (da) 2011-06-27
ES2362040T3 (es) 2011-06-27
EP1436320A1 (de) 2004-07-14
EP1436320A4 (de) 2004-12-15

Similar Documents

Publication Publication Date Title
NO20045021L (no) Immunologiske metoder og preparater for behandling av Alzheimers sykdom
EP2368907A3 (de) Anti-Abeta-Antikörper und ihre Verwendung
DE60114018D1 (de) Von zellen präsentierte peptide
ATE256185T1 (de) T-zell-membranprotein (tirc7), davon abgeleitete peptide und antikörper und ihre verwendungen
DE69931482D1 (de) Isolierte peptide die aminosäuresequenzen von ny-eso-1 entsprechen und an mhc-klasse i und mhc klasse ii moleküle binden, und deren verwendungen
EP1436320A4 (de) T-zellen-epitope des cyn-d-1-allergens aus bermudagraspollen
EP1546188A4 (de) P53 bindende t-zellrezeptormoleküle und deren verwendungen
DK1025849T5 (da) Fremgangsmåder til påvisning og behandling af individer, som har unormale celler, som udtrykker HLC-A2/tyrosinasepeptid-antigener
DE69517521D1 (de) Peptid aus dem inneren des hepatitis-c-virus brauchbar für die stimulation cytotoxischer t-lymphocyten und die diagnose des hcv-kontaktes
WO2003082924A8 (en) Immunotherapeutic and immunoprophylactic reagents
NZ707615A (en) Novel immunotherapeutic molecules and uses thereof
NO943811L (no) T-celle-epitoper av hovedallergenene fra Ambriosa artemisiifolia
ATE312921T1 (de) Antigene polypeptide aus neisseria meningitidis, dafür kodierende polynukleotide und entsprechende schützende antikörper
DK0968288T3 (da) z219a, en human homolog til 2-19 protein
WO2004014936A3 (fr) Melange de peptides issus des proteines c et ns3 du virus de l'hepatite c et leurs applications.
CA2270877A1 (en) Peptide-based immunotherapeutic agent
WO2001068861A3 (en) THREE-DIMENSIONAL MODEL OF A Fc REGION OF AN IgE ANTIBODY AND USES THEREOF
DE69934098D1 (de) Neues diagnostisches reagens und kit zur erkennung von rickettsiose
DK0972781T3 (da) Protein S-polypeptider og anvendelser deraf
AU2003260546A8 (en) Device for the presentation of peptides or proteins, method for the preparation and use thereof
CA2140091A1 (en) Peptides and antisera for detecting human cyclooxygenase-1 and cyclooxygenase-2
Eberl et al. A simple mathematical model for the functional peptide/MHC/TCR interactions.
DE60038551D1 (de) Peptidepitope die von krankheitsfördernden cd4+ t lymphocyten erkannt werden
ATE338063T1 (de) Diagnostische verwendungen des t-zell proteins tzon7, der davon abgeleiteten peptide und des antikörpers
DE60237588D1 (de) Neue trp2-isoform mit cytotoxischen t-lymphozyten-epitopen mit hla-a2-restriktion

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties